Function and importance of p63 in normal oral mucosa and squamous cell carcinoma of the head and neck

Advances in Oto-Rhino-Laryngology

Volumn 62, Issue , 2005, Pages 49-57

  Thurfjell, Niklas ^a   Coates, Philip J ^c   Boldrup, Linda ^a   Lindgren, Britta ^a   Bäcklund, Bodil ^a   Uusitalo, Tony ^a   Mahani, David ^a   Dabelsteen, Erik ^d   Dahlqvist, Åke ^b   Sjöström, Björn ^b   Roos, Göran ^a   Vojtesek, Borek ^e   Nenutil, Rudolf ^f   Nylander, Karin ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^f Maternity Hospital   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53; TUMOR MARKER;

ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; EPIDEMIOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METHODOLOGY; MORTALITY; MOUTH MUCOSA; NEEDLE BIOPSY; PATHOLOGY; PROGNOSIS; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOUTH MUCOSA; PROGNOSIS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 16644367764     PISSN: 00653071     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (16)

1. MacFarlane GJ, Boyle P, Evstifeeva TV, Robertson C, Scully C: Rising trends of oral cancer mortality among males worldwide: The return of an old public health problem. Cancer Causes Control 1994;5:259-265.
2. Carter R: Pathology of squamous carcinomas of the head and neck. Current Opin Oncol 1992;4:485-490.
3. Bockmühl U, Schlüns K, Küchler I, Petersen S, Petersen I: Genetic imbalances with impact on survival in head and neck patients. Am J Pathol 2000;157:369-375.
4. Schmale H, Bamberger C: A novel protein with strong homology to the tumor suppressor p53. Oncogene 1997;15:1363-1367.
5. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809-819.
6. Yang A, Kagdah M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D, McKeon F: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305-316.
7. Osada M, Ohba M, Kawahara C, Ishioka C, Kanamura R, et al: Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 1998;4:839-843.
8. Ghioni P, Bolognese F, Dujif PHG, van Bokhoven H, Mantovani R, Guerrini L: Complex transcriptional effects of p63 isoforms: Identification of novel activation and repression domains. Mol Cell Biol 2002;22:8659-8668.
9. Serber Z, Lai HC, Yang A, Ou HD, Sigal MS, Kelly AE, Darimont BD, Dujif PHG, van Bokhoven H, McKeon F, Dötsch V: A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol Cell Biol 2002;22:8601-8611.
10. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F: p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714-718.
11. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A: p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999;398:708-713.
12. Hall PA, Campbell SJ, O'Neill M, Royston DJ, Nylander K, Carey FA, Kernohan NM: The expression of the p53 homologue, p63α and ΔNp63α in normal and neoplastic cells. Carcinogenesis 2000;21:153-160.
13. Nylander K, Coates PJ, Hall PA: Characterisation of the expression pattern of p63α and ΔNp63α in benign and malignant oral epithelial lesions. Int J Cancer 2000;87:368-372.
14. Nylander K, Vojtesek B, Nenutil R, Lindgren B, Roos G, Zhanxiang W, Sjöström B, Dahlqvist Å, Coates PJ: Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 2002;198:417-427.
15. Thurfjell N, Coates PJ, Mahani D, Uusitalo T, Dabelsteen E, Dahlqvist Å, Sjöström B, Nylander K: Levels of different p63 isoforms in normal nonexposed and tobacco exposed oral mucosa and squamous cell carcinomas of the head and neck. Int J Oncol 2004;25:27-35.
16. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, Jacks T: p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002;416:560-564.